Literature DB >> 28097769

High resolution crystal structures of human kynurenine aminotransferase-I bound to PLP cofactor, and in complex with aminooxyacetate.

Naveed A Nadvi1,2, Noeris K Salam1, Joohong Park2, Fady N Akladios1, Vimal Kapoor3, Charles A Collyer4, Mark D Gorrell2, William Bret Church1.   

Abstract

In this study, we report two high-resolution structures of the pyridoxal 5' phosphate (PLP)-dependent enzyme kynurenine aminotransferase-I (KAT-I). One is the native structure with the cofactor in the PLP form bound to Lys247 with the highest resolution yet available for KAT-I at 1.28 Å resolution, and the other with the general PLP-dependent aminotransferase inhibitor, aminooxyacetate (AOAA) covalently bound to the cofactor at 1.54 Å. Only small conformational differences are observed in the vicinity of the aldimine (oxime) linkage with which the PLP forms the Schiff base with Lys247 in the 1.28 Å resolution native structure, in comparison to other native PLP-bound structures. We also report the inhibition of KAT-1 by AOAA and aminooxy-phenylpropionic acid (AOPP), with IC50s of 13.1 and 5.7 μM, respectively. The crystal structure of the enzyme in complex with the inhibitor AOAA revealed that the cofactor is the PLP form with the external aldimine linkage. The location of this oxime with the PLP, which forms in place of the native internal aldimine linkage of PLP of the native KAT-I, is away from the position of the native internal aldimine, with the free Lys247 substantially retaining the orientation of the native structure. Tyr101, at the active site, was observed in two conformations in both structures.
© 2017 The Protein Society.

Entities:  

Keywords:  aminotransferase; kynurenic acid; kynurenine; pyridoxyl phosphate; transferase

Mesh:

Substances:

Year:  2017        PMID: 28097769      PMCID: PMC5368072          DOI: 10.1002/pro.3119

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  50 in total

1.  Purification and characterization of kynurenine-pyruvate aminotransferase from rat kidney and brain.

Authors:  E Okuno; F Du; T Ishikawa; M Tsujimoto; M Nakamura; R Schwarcz; R Kido
Journal:  Brain Res       Date:  1990-11-26       Impact factor: 3.252

2.  The glutamine transaminase-omega-amidase system in rat and human brain.

Authors:  A J Cooper; M Gross
Journal:  J Neurochem       Date:  1977-04       Impact factor: 5.372

3.  Aminooxyacetate is not an adequate differential inhibitor of aspartate aminotransferase isoenzymes.

Authors:  R Rej
Journal:  Clin Chem       Date:  1977-08       Impact factor: 8.327

4.  Crystal structures and solution studies of oxime adducts of mitochondrial aspartate aminotransferase.

Authors:  Z Marković-Housley; T Schirmer; E Hohenester; A R Khomutov; R M Khomutov; M Y Karpeisky; E Sandmeier; P Christen; J N Jansonius
Journal:  Eur J Biochem       Date:  1996-03-15

5.  A mechanism of quinolinic acid formation by brain in inflammatory neurological disease. Attenuation of synthesis from L-tryptophan by 6-chlorotryptophan and 4-chloro-3-hydroxyanthranilate.

Authors:  M P Heyes; K Saito; E O Major; S Milstien; S P Markey; J H Vickers
Journal:  Brain       Date:  1993-12       Impact factor: 13.501

6.  Increased cortical kynurenate content in schizophrenia.

Authors:  R Schwarcz; A Rassoulpour; H Q Wu; D Medoff; C A Tamminga; R C Roberts
Journal:  Biol Psychiatry       Date:  2001-10-01       Impact factor: 13.382

7.  Biochemical and phenotypic abnormalities in kynurenine aminotransferase II-deficient mice.

Authors:  Ping Yu; Nicholas A Di Prospero; Michael T Sapko; Tao Cai; Amy Chen; Miguel Melendez-Ferro; Fu Du; William O Whetsell; Paolo Guidetti; Robert Schwarcz; Danilo A Tagle
Journal:  Mol Cell Biol       Date:  2004-08       Impact factor: 4.272

Review 8.  L-kynurenine: its synthesis and possible regulatory function in brain.

Authors:  E M Gál; A D Sherman
Journal:  Neurochem Res       Date:  1980-03       Impact factor: 3.996

9.  Biochemical properties and crystal structure of a β-phenylalanine aminotransferase from Variovorax paradoxus.

Authors:  Ciprian G Crismaru; Gjalt G Wybenga; Wiktor Szymanski; Hein J Wijma; Bian Wu; Sebastian Bartsch; Stefaan de Wildeman; Gerrit J Poelarends; Ben L Feringa; Bauke W Dijkstra; Dick B Janssen
Journal:  Appl Environ Microbiol       Date:  2012-10-19       Impact factor: 4.792

10.  Phaser crystallographic software.

Authors:  Airlie J McCoy; Ralf W Grosse-Kunstleve; Paul D Adams; Martyn D Winn; Laurent C Storoni; Randy J Read
Journal:  J Appl Crystallogr       Date:  2007-07-13       Impact factor: 3.304

View more
  4 in total

Review 1.  Cystathionine-β-Synthase: Molecular Regulation and Pharmacological Inhibition.

Authors:  Karim Zuhra; Fiona Augsburger; Tomas Majtan; Csaba Szabo
Journal:  Biomolecules       Date:  2020-04-30

2.  Improvement of kynurenine aminotransferase-II inhibitors guided by mimicking sulfate esters.

Authors:  Gayan S Jayawickrama; Alireza Nematollahi; Guanchen Sun; William Bret Church
Journal:  PLoS One       Date:  2018-04-24       Impact factor: 3.240

3.  H2S biogenesis by cystathionine beta-synthase: mechanism of inhibition by aminooxyacetic acid and unexpected role of serine.

Authors:  Maria Petrosino; Karim Zuhra; Jola Kopec; Andrew Hutchin; Csaba Szabo; Tomas Majtan
Journal:  Cell Mol Life Sci       Date:  2022-07-21       Impact factor: 9.207

4.  Inhibition of human kynurenine aminotransferase isozymes by estrogen and its derivatives.

Authors:  Gayan S Jayawickrama; Alireza Nematollahi; Guanchen Sun; Mark D Gorrell; W Bret Church
Journal:  Sci Rep       Date:  2017-12-14       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.